The risk assessment of daily oral hormonal feminine contraception: an overview of current controversies
The following paper links the medicalization with daily oral hormonal feminine contraception and its process of risk assessment, issues whose importance has grown in the public debates of the last decades. From this point of view, diverse “paradigms” get shaped across the time, as ways of prioritizi...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo revista |
| Lenguaje: | Español |
| Publicado: |
Facultad de Humanidades y Artes. UNR
2019
|
| Materias: | |
| Acceso en línea: | https://zonafranca.unr.edu.ar/index.php/ZonaFranca/article/view/112 |
| Aporte de: |
| Sumario: | The following paper links the medicalization with daily oral hormonal feminine contraception and its process of risk assessment, issues whose importance has grown in the public debates of the last decades. From this point of view, diverse “paradigms” get shaped across the time, as ways of prioritizing benefits or side effects in the commercialization or administration of the “pill”. Those go together, of course, with the evolution of sexual and reproductive health models. This capital dimension of analysis, brings to light the risk, not only as an objective fact, but also and mostly as a result of the intersection of socio-cultural, economic and politic factors. Dimension which takes also place in a vast literature that questions the feminine hormonal contraception, its liberalizing quality for women and its role perpetuating gender inequalities. |
|---|